In March, medical imaging company CoreLab Partners, which was created out of the merger of RadPharm and Medifacts International in December, had raised $4.7m from 10 investors, according to its regulatory filing.??

CoreLab Partners has nearly doubled the amount it has collected in its latest round with an updated regulatory filing showing the company raising $8.7m of a planned $11.7m total.

In March, medical imaging company CoreLab Partners, which was created out of the merger of RadPharm and Medifacts International in December, raised $4.7m from 10 investors, according to its regulatory filing.



Although there is no statement, Andrew Jay, managing partner of Siemens Venture Capital, is named as a director of CoreLab. Other investors include venture capital firms Ampersand Ventures and SV Life Sciences, according to news provider Mass High Tech that first noticed the filing.